Leptin in depression: a potential therapeutic target

被引:0
|
作者
Tongtong Ge
Jie Fan
Wei Yang
Ranji Cui
Bingjin Li
机构
[1] The Second Hospital of Jilin University,Jilin Provincial Key Laboratory on Molecular and Chemical Genetics
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Leptin, produced and secreted by white adipose tissue, plays a critical role in regulating body weight, food intake, and energy metabolism. Recently, several studies have identified an underlying role for leptin in regulation of mood and cognition via regulation of synaptic changes in the brain that have been associated with antidepressant-like actions. Brain neural plasticity occurs in response to a range of intrinsic and extrinsic stimuli, including those that may mediate the effects of antidepressants. Neural plasticity theories of depression are thought to explain multiple aspects of depression and the effects of antidepressants. It is also well documented that leptin has effects on neural plasticity. This review summarizes the recent literature on the role of leptin in neural plasticity in order to elaborate the possible mechanism of leptin’s antidepressant-like effects. Recent findings provide new insights into the underlying mechanisms of neural plasticity in depression. Leptin may influence these mechanisms and consequently constitute a possible target for novel therapeutic approaches to the treatment of depression.
引用
收藏
相关论文
共 50 条
  • [1] Leptin in depression: a potential therapeutic target
    Ge, Tongtong
    Fan, Jie
    Yang, Wei
    Cui, Ranji
    Li, Bingjin
    [J]. CELL DEATH & DISEASE, 2018, 9
  • [2] VEGF as a potential target for therapeutic intervention in depression
    Warner-Schmidt, Jennifer L.
    Duman, Ronald S.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) : 14 - 19
  • [3] Leptin as a potential therapeutic target for breast cancer prevention and treatment
    Ray, Amitbha
    Cleary, Margot P.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (04) : 443 - 451
  • [4] The therapeutic potential of leptin
    Proietto, J
    Thorburn, AW
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) : 373 - 378
  • [5] IDO and TDO as a potential therapeutic target in different types of depression
    Qin, Yanjie
    Wang, Nanxi
    Zhang, Xinlin
    Han, Xuemei
    Zhai, Xuejia
    Lu, Yongning
    [J]. METABOLIC BRAIN DISEASE, 2018, 33 (06) : 1787 - 1800
  • [6] IDO and TDO as a potential therapeutic target in different types of depression
    Yanjie Qin
    Nanxi Wang
    Xinlin Zhang
    Xuemei Han
    Xuejia Zhai
    Yongning Lu
    [J]. Metabolic Brain Disease, 2018, 33 : 1787 - 1800
  • [7] Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target
    Calabrese, Francesca
    Riva, Marco A.
    Molteni, Raffaella
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (10) : 1195 - 1207
  • [8] Purinergic signaling: a potential therapeutic target for depression and chronic pain
    Zou, Yuting
    Yang, Runan
    Li, Lin
    Xu, Xiumei
    Liang, Shangdong
    [J]. PURINERGIC SIGNALLING, 2023, 19 (01) : 163 - 172
  • [9] Purinergic signaling: a potential therapeutic target for depression and chronic pain
    Yuting Zou
    Runan Yang
    Lin Li
    Xiumei Xu
    Shangdong Liang
    [J]. Purinergic Signalling, 2023, 19 : 163 - 172
  • [10] Leptin signaling as a therapeutic target of obesity
    Sainz, Neira
    Gonzalez-Navarro, Carlos J.
    Alfredo Martinez, J.
    Moreno-Aliaga, Maria J.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (07) : 893 - 909